Olga Kholmanskikh

Interleukins 1α and 1β secreted by some melanoma cell lines strongly reduce expression of MITF‐M and melanocyte differentiation antigens

Olga Kholmanskikh, Nicolas van Baren, Francis Brasseur et al. · International Journal of Cancer · 2010 · 68 citations

Life Sciences, Cell Biology, Immunology +17

Expression of <i>BORIS</i> in melanoma: Lack of association with <i>MAGE‐A1</i> activation

Olga Kholmanskikh, Axelle Loriot, Francis Brasseur et al. · International Journal of Cancer · 2007 · 60 citations · Full text

Life Sciences, Genetics, Oncology +13

Enhancing reporting quality and impact of early phase dose-finding clinical trials: CONSORT Dose-finding Extension (CONSORT-DEFINE) guidance

Christina Yap, Olga Solovyeva, Johann S. de Bono et al. · BMJ · 2023 · 47 citations · Full text

Pharmacy, Pharmacology, Clinical Pharmacology +12

Enhancing quality and impact of early phase dose-finding clinical trial protocols: SPIRIT Dose-finding Extension (SPIRIT-DEFINE) guidance

Christina Yap, Jan Rekowski, Moreno Ursino et al. · BMJ · 2023 · 26 citations · Full text

Medicine, Pharmacology, Clinical Pharmacology +9

2023 White Paper on Recent Issues in Bioanalysis: EU IVDR 2017/746 Implementation/Impact, IVD/CDx/CLIA Approved Assays, High Dimensional Cytometry, Multiplexing Technologies, LBA Tissue Analysis, Vaccine Study Endpoints, Cell-Based Assays for Biomarkers, Cell Therapy and Vaccines ( <u>PART 2</u> – Recommendations on Development &amp; Validation of Biomarkers, IVD, CDx, Cell-Based, Flow Cytometry, Ligand-Binding and Enzyme Assays; Advanced Critical Reagents Strategies)

Olga Kholmanskikh, Yow‐Ming Wang, Sarah Hersey et al. · Bioanalysis · 2024 · 11 citations · Full text

Pharmacy, Biomedical Sciences, Immunology +17